imatinib mesylate has been researched along with Retinal Neovascularization in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Agostini, H; Bengsch, B; Böhringer, D; Boneva, SK; Bucher, F; Busch, M; Faatz, H; Hajdú, RI; Killmer, S; Laich, Y; Lange, CAK; Lommatzsch, A; Prinz, G; Salié, H; Schlecht, A; Schlunck, G; Stahl, A; Wolf, J | 1 |
| Cheng, B; He, C; Huang, Z; Li, M; Liu, X; Liu, Y; Sun, X; Wang, J; Zhou, L; Zhou, T; Zhu, X | 1 |
| Chikh, A; Denti, L; Fantin, A; Lampropoulou, A; Raimondi, C; Ruhrberg, C | 1 |
| Gulati, AP; Saif, MW | 1 |
| Bartlett, HM; Costakos, D; Mandava, N | 1 |
| Andrade-Gordon, P; Friedlander, M; Kurokawa, T; Mueller, BM; Ruf, W; Uusitalo-Jarvinen, H | 1 |
6 other study(ies) available for imatinib mesylate and Retinal Neovascularization
| Article | Year |
|---|---|
In-Depth Molecular Characterization of Neovascular Membranes Suggests a Role for Hyalocyte-to-Myofibroblast Transdifferentiation in Proliferative Diabetic Retinopathy.
Topics: Adult; Aged; Cell Transdifferentiation; Cells, Cultured; Computational Biology; Diabetic Retinopathy; Drug Repositioning; Endothelial Cells; Epiretinal Membrane; Eye Proteins; Female; Gene Ontology; Humans; Imatinib Mesylate; Immunologic Factors; Male; Middle Aged; Myofibroblasts; Retinal Neovascularization; Retinal Perforations; Single-Cell Analysis; Transcriptome; Vitreous Body; Young Adult | 2021 |
Imatinib Ameliorated Retinal Neovascularization by Suppressing PDGFR-α and PDGFR-β.
Topics: Angiogenesis Inhibitors; Animals; Cell Proliferation; Disease Models, Animal; Endothelial Cells; Fibroblast Growth Factor 2; Hypoxia-Inducible Factor 1, alpha Subunit; Imatinib Mesylate; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocytes, Smooth Muscle; Pericytes; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Retina; Retinal Neovascularization; Vascular Endothelial Growth Factor A | 2018 |
Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells.
Topics: Animals; Benzamides; Cell Adhesion; Cell Movement; Cells, Cultured; Endothelial Cells; Enzyme Activation; Fibronectins; Humans; Imatinib Mesylate; Immunoblotting; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microscopy, Confocal; Neovascularization, Physiologic; Neuropilin-1; Paxillin; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrimidines; Retinal Neovascularization; RNA Interference; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2014 |
Retinal neovascularization and hemorrhage associated with the use of imatinib (Gleevec(®)) in a patient being treated for gastrointestinal stromal tumor (GIST).
Topics: Antineoplastic Agents; Benzamides; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Pyrimidines; Retinal Hemorrhage; Retinal Neovascularization | 2012 |
Chronic myelogenous leukemia manifested as bilateral proliferative retinopathy.
Topics: Adult; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Fluorescein Angiography; Humans; Hydroxyurea; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Pyrimidines; Retinal Neoplasms; Retinal Neovascularization | 2005 |
Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis.
Topics: Animals; Benzamides; Blood Coagulation Factor Inhibitors; Cell Line, Tumor; Disease Models, Animal; Factor VIIa; Hyperoxia; Hypoxia; Imatinib Mesylate; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Neoplasms, Experimental; Neovascularization, Pathologic; Oxygen; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Receptor, PAR-1; Receptor, PAR-2; Retinal Neovascularization; Retinal Vessels; Signal Transduction; Thromboplastin; Time Factors | 2007 |